ABBV: Approves SKYRIZI for Pediatric Psoriasis
AbbVie announces European Commission approval of SKYRIZI for treating pediatric patients with moderate to severe plaque psoriasis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.